Cargando…
MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease
Autores principales: | Hegemann, Inga, Sasselli, Clelia, Valeri, Fabio, Makhro, Asya, Müller, Rouven, Bogdanova, Anna, Manz, Markus G., Gassmann, Max, Goede, Jeroen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430229/ https://www.ncbi.nlm.nih.gov/pubmed/32885144 http://dx.doi.org/10.1097/HS9.0000000000000452 |
Ejemplares similares
-
A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment
por: Mahkro, Asya, et al.
Publicado: (2020) -
The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism
por: Peretz, Sari, et al.
Publicado: (2022) -
5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
por: Levin, C.L., et al.
Publicado: (2023) -
PB2222: THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.
por: Peretz, S., et al.
Publicado: (2022) -
Calcium in Red Blood Cells—A Perilous Balance
por: Bogdanova, Anna, et al.
Publicado: (2013)